OR WAIT null SECS
October 02, 2012
The authors examine the use of various grades of direct-compression mannitol in direct-compression tableting process to evaluate the content uniformity of micronized APIs and excipients in a solid-dosage formulation.
Particle-engineering technologies, such as crystal design for crystallization and producting cocrystals, particle-size reduction, and amorphous solid dispersions, help to optimize delivery of a drug.
The long-awaited patent cliff that has loomed in the pharmaceutical industry for years has arrived in earnest in 2012, with more than $40 billion in 2011 brand sales facing loss of exclusivity.
September 04, 2012
Bristol-Myers Squibb has initiated a voluntary recall of 10 lots of BiCNU (carmustine for injection) previously manufactured by Ben Venue Laboratories, a former, third-party contract manufacturer for the company, to the user level.
September 02, 2012
A review of taints and odors in the pharmaceutical and consumer healthcare industries.
Industry and academia advance novel approaches for achieving enanioselectivity.
The authors investigate the tablet-coating process using a combination of different simulation techniques.
September 01, 2012
Pfizer has two manufacturing facilities in Germany for high-potency manufacturing, respectively in Freiburg and Illertissen. Pharmaceutical Technology's Executive Editor Patricia Van Arnum visited the facilities and spoke to the company about the design and operation of these facilities.
The authors describe a QbD study that was performed to optimize a coating system.
The authors explain chemical transformations that are achievable through certain biocatalytic routes.